ICD-10-PCS › 3
ICD-10-PCS codes starting with 3
1,516 codes, page 6 of 16. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| 3E040XZ | Introduction of Vasopressor into Central Vein, Open Approach | Valid |
| 3E04302 | Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach | Valid |
| 3E04303 | Introduction of Low-dose Interleukin-2 into Central Vein, Percutaneous Approach | Valid |
| 3E04305 | Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach | Valid |
| 3E0430M | Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach | Valid |
| 3E0430P | Introduction of Clofarabine into Central Vein, Percutaneous Approach | Valid |
| 3E04316 | Introduction of Recombinant Human-activated Protein C into Central Vein, Percutaneous | Valid |
| 3E04317 | Introduction of Other Thrombolytic into Central Vein, Percutaneous Approach | Valid |
| 3E04328 | Introduction of Oxazolidinones into Central Vein, Percutaneous Approach | Valid |
| 3E04329 | Introduction of Other Anti-infective into Central Vein, Percutaneous Approach | Valid |
| 3E0433Z | Introduction of Anti-inflammatory into Central Vein, Percutaneous Approach | Valid |
| 3E0434Z | Introduction of Serum, Toxoid and Vaccine into Central Vein, Percutaneous Approach | Valid |
| 3E0436Z | Introduction of Nutritional Substance into Central Vein, Percutaneous Approach | Valid |
| 3E0437Z | Introduction of Electrolytic and Water Balance Substance into Central Vein, Percutaneous Approach | Valid |
| 3E043AZ | Introduction of Embryonic Stem Cells into Central Vein, Percutaneous Approach | Valid |
| 3E043FZ | Introduction of Intracirculatory Anesthetic into Central Vein, Percutaneous Approach | Valid |
| 3E043GC | Introduction of Other Therapeutic Substance into Central Vein, Percutaneous Approach | Valid |
| 3E043GN | Introduction of Blood Brain Barrier Disruption Substance into Central Vein, Percutaneous Approach | Valid |
| 3E043GQ | Introduction of Glucarpidase into Central Vein, Percutaneous Approach | Valid |
| 3E043GR | Introduction of Other Therapeutic Monoclonal Antibody into Central Vein, Percutaneous Approach | Valid |
| 3E043HZ | Introduction of Radioactive Substance into Central Vein, Percutaneous Approach | Valid |
| 3E043KZ | Introduction of Other Diagnostic Substance into Central Vein, Percutaneous Approach | Valid |
| 3E043NZ | Introduction of Analgesics, Hypnotics, Sedatives into Central Vein, Percutaneous Approach | Valid |
| 3E043PZ | Introduction of Platelet Inhibitor into Central Vein, Percutaneous Approach | Valid |
| 3E043RZ | Introduction of Antiarrhythmic into Central Vein, Percutaneous Approach | Valid |
| 3E043TZ | Introduction of Destructive Agent into Central Vein, Percutaneous Approach | Valid |
| 3E043VG | Introduction of Insulin into Central Vein, Percutaneous Approach | Valid |
| 3E043VH | Introduction of Human B-type Natriuretic Peptide into Central Vein, Percutaneous Approach | Valid |
| 3E043VJ | Introduction of Other Hormone into Central Vein, Percutaneous Approach | Valid |
| 3E043WK | Introduction of Immunostimulator into Central Vein, Percutaneous | Valid |
| 3E043WL | Introduction of Immunosuppressive into Central Vein, Percutaneous | Valid |
| 3E043XZ | Introduction of Vasopressor into Central Vein, Percutaneous Approach | Valid |
| 3E05002 | Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach | Valid |
| 3E05003 | Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach | Valid |
| 3E05005 | Introduction of Other Antineoplastic into Peripheral Artery, Open Approach | Valid |
| 3E0500M | Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach | Valid |
| 3E0500P | Introduction of Clofarabine into Peripheral Artery, Open Approach | Valid |
| 3E05016 | Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Open | Valid |
| 3E05017 | Introduction of Other Thrombolytic into Peripheral Artery, Open Approach | Valid |
| 3E05028 | Introduction of Oxazolidinones into Peripheral Artery, Open Approach | Valid |
| 3E05029 | Introduction of Other Anti-infective into Peripheral Artery, Open Approach | Valid |
| 3E0503Z | Introduction of Anti-inflammatory into Peripheral Artery, Open Approach | Valid |
| 3E0504Z | Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Open Approach | Valid |
| 3E0506Z | Introduction of Nutritional Substance into Peripheral Artery, Open Approach | Valid |
| 3E0507Z | Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Open Approach | Valid |
| 3E050FZ | Introduction of Intracirculatory Anesthetic into Peripheral Artery, Open Approach | Valid |
| 3E050GC | Introduction of Other Therapeutic Substance into Peripheral Artery, Open Approach | Valid |
| 3E050GN | Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Open Approach | Valid |
| 3E050HZ | Introduction of Radioactive Substance into Peripheral Artery, Open Approach | Valid |
| 3E050KZ | Introduction of Other Diagnostic Substance into Peripheral Artery, Open Approach | Valid |
| 3E050NZ | Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Open Approach | Valid |
| 3E050PZ | Introduction of Platelet Inhibitor into Peripheral Artery, Open Approach | Valid |
| 3E050RZ | Introduction of Antiarrhythmic into Peripheral Artery, Open Approach | Valid |
| 3E050TZ | Introduction of Destructive Agent into Peripheral Artery, Open Approach | Valid |
| 3E050VG | Introduction of Insulin into Peripheral Artery, Open Approach | Valid |
| 3E050VH | Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Open Approach | Valid |
| 3E050VJ | Introduction of Other Hormone into Peripheral Artery, Open Approach | Valid |
| 3E050WK | Introduction of Immunostimulator into Peripheral Artery, Open | Valid |
| 3E050WL | Introduction of Immunosuppressive into Peripheral Artery, Open | Valid |
| 3E050XZ | Introduction of Vasopressor into Peripheral Artery, Open Approach | Valid |
| 3E05302 | Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach | Valid |
| 3E05303 | Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach | Valid |
| 3E05305 | Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach | Valid |
| 3E0530M | Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach | Valid |
| 3E0530P | Introduction of Clofarabine into Peripheral Artery, Percutaneous Approach | Valid |
| 3E05316 | Introduction of Recombinant Human-activated Protein C into Peripheral Artery, Percutaneous | Valid |
| 3E05317 | Introduction of Other Thrombolytic into Peripheral Artery, Percutaneous Approach | Valid |
| 3E05328 | Introduction of Oxazolidinones into Peripheral Artery, Percutaneous Approach | Valid |
| 3E05329 | Introduction of Other Anti-infective into Peripheral Artery, Percutaneous Approach | Valid |
| 3E0533Z | Introduction of Anti-inflammatory into Peripheral Artery, Percutaneous Approach | Valid |
| 3E0534Z | Introduction of Serum, Toxoid and Vaccine into Peripheral Artery, Percutaneous Approach | Valid |
| 3E0536Z | Introduction of Nutritional Substance into Peripheral Artery, Percutaneous Approach | Valid |
| 3E0537Z | Introduction of Electrolytic and Water Balance Substance into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053FZ | Introduction of Intracirculatory Anesthetic into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053GC | Introduction of Other Therapeutic Substance into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053GN | Introduction of Blood Brain Barrier Disruption Substance into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053HZ | Introduction of Radioactive Substance into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053KZ | Introduction of Other Diagnostic Substance into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053NZ | Introduction of Analgesics, Hypnotics, Sedatives into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053PZ | Introduction of Platelet Inhibitor into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053RZ | Introduction of Antiarrhythmic into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053TZ | Introduction of Destructive Agent into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053VG | Introduction of Insulin into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053VH | Introduction of Human B-type Natriuretic Peptide into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053VJ | Introduction of Other Hormone into Peripheral Artery, Percutaneous Approach | Valid |
| 3E053WK | Introduction of Immunostimulator into Peripheral Artery, Percutaneous | Valid |
| 3E053WL | Introduction of Immunosuppressive into Peripheral Artery, Percutaneous | Valid |
| 3E053XZ | Introduction of Vasopressor into Peripheral Artery, Percutaneous Approach | Valid |
| 3E06002 | Introduction of High-dose Interleukin-2 into Central Artery, Open Approach | Valid |
| 3E06003 | Introduction of Low-dose Interleukin-2 into Central Artery, Open Approach | Valid |
| 3E06005 | Introduction of Other Antineoplastic into Central Artery, Open Approach | Valid |
| 3E0600M | Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approach | Valid |
| 3E0600P | Introduction of Clofarabine into Central Artery, Open Approach | Valid |
| 3E06016 | Introduction of Recombinant Human-activated Protein C into Central Artery, Open | Valid |
| 3E06017 | Introduction of Other Thrombolytic into Central Artery, Open Approach | Valid |
| 3E06028 | Introduction of Oxazolidinones into Central Artery, Open Approach | Valid |
| 3E06029 | Introduction of Other Anti-infective into Central Artery, Open Approach | Valid |
| 3E0603Z | Introduction of Anti-inflammatory into Central Artery, Open Approach | Valid |
| 3E0604Z | Introduction of Serum, Toxoid and Vaccine into Central Artery, Open Approach | Valid |
| 3E0606Z | Introduction of Nutritional Substance into Central Artery, Open Approach | Valid |